NRXP
NRX Pharmaceuticals Inc
3.20$
-4.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +1.8% | -54.7% | -90.8% | +1,012.9% | -21.1% | -71.7% | -50.1% | +254.9% | |
| – | -94.4% | +130.1% | +4,116.5% | +1,016.5% | -21.1% | -73.3% | -52.0% | +169.3% | |
| – | -97.5% | -99.9% | +30,983,233.3% | +1,384.9% | -27.4% | -77.1% | -68.6% | +440.3% | |
| – | -97.5% | -99.9% | +30,983,233.3% | +1,384.9% | -27.4% | -77.1% | -68.6% | +440.3% | |
| – | – | – | – | -100.0% | – | -14.3% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +1,249.6% | +104.7% | +1,714.6% | -74.5% | +54.4% | +3.5% | +41.1% | +7.5% | |
| – | +509.0% | +9.7% | +7,316.6% | -74.2% | +30.7% | +22.2% | +14.8% | +30.7% | |
| – | – | – | – | +108.0% | +1,387.1% | +18.9% | -82.9% | -79.8% | |
| – | +543.3% | +12.9% | +406.6% | +16.9% | -43.7% | +123.1% | -10.8% | +3.4% | |
| – | – | +182.9% | +36.9% | – | – | – | – | – | |
| – | +0.1% | -57.6% | -248.4% | – | -64.4% | -258.4% | – | – | |
| – | – | – | -24,506.3% | – | – | – | – | – | |
| – | -1.2% | -43.0% | +7.4% | +8,483.8% | +40.2% | -88.5% | +38.8% | +103.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.